Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Makoto Horikawa
Recurrent Triple-Negative Breast Cancer (TNBC) Tissues Contain a Higher Amount of Phosphatidylcholine (32:1) Than Non-Recurrent TNBC Tissues
PLoS ONE
Multidisciplinary
Nicotinamide Adenine Dinucleotide Extends the Lifespan of Caenorhabditis Elegans Mediated by Sir-2.1 and Daf-16
Biogerontology
Aging
Gerontology
Geriatrics
Related publications
Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here
Cancer
Cancer Research
Oncology
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
Case Reports in Oncological Medicine
Oncology
Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) With High Stearoyl-CoA Desaturase-1 Expression
PLoS ONE
Multidisciplinary
Germline TP53 and MSH6 Mutations Implicated in Sporadic Triple-Negative Breast Cancer (TNBC): A Preliminary Study
Human Genomics
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Failure Patterns and Survival Outcomes in Triple Negative Breast Cancer (TNBC): A 15 Year Comparison of 448 Non-Hispanic Black and White Women
SpringerPlus
Multidisciplinary
Recurrent CYP2C19 Deletion Allele Is Associated With Triple-Negative Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
The Length of the Bridging Chain in Ansa-Metallocenes Influences Their Antiproliferative Activity Against Triple Negative Breast Cancer Cells (TNBC)
Dalton Transactions
Inorganic Chemistry
Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
miR-425 Suppresses EMT and the Development of TNBC (Triple-Negative Breast Cancer) by Targeting the TGF-β 1/Smad 3 Signaling Pathway
RSC Advances
Chemistry
Chemical Engineering
